S&P 500   4,426.18 (+1.60%)
DOW   34,664.64 (+1.07%)
QQQ   352.88 (+2.25%)
AAPL   162.92 (+1.97%)
MSFT   301.66 (+4.57%)
FB   302.65 (+0.83%)
GOOGL   2,632.00 (+3.68%)
AMZN   2,836.55 (+1.32%)
TSLA   955.76 (+4.07%)
NVDA   233.39 (+4.55%)
BABA   116.19 (-2.48%)
NIO   23.72 (-0.29%)
AMD   113.86 (+2.46%)
CGC   7.61 (+3.40%)
MU   83.75 (+3.75%)
GE   90.71 (-0.44%)
T   25.29 (-4.49%)
F   20.24 (+1.30%)
DIS   137.34 (+0.61%)
AMC   17.47 (+9.05%)
PFE   53.20 (+1.26%)
ACB   4.25 (+0.95%)
BA   197.79 (-3.09%)
S&P 500   4,426.18 (+1.60%)
DOW   34,664.64 (+1.07%)
QQQ   352.88 (+2.25%)
AAPL   162.92 (+1.97%)
MSFT   301.66 (+4.57%)
FB   302.65 (+0.83%)
GOOGL   2,632.00 (+3.68%)
AMZN   2,836.55 (+1.32%)
TSLA   955.76 (+4.07%)
NVDA   233.39 (+4.55%)
BABA   116.19 (-2.48%)
NIO   23.72 (-0.29%)
AMD   113.86 (+2.46%)
CGC   7.61 (+3.40%)
MU   83.75 (+3.75%)
GE   90.71 (-0.44%)
T   25.29 (-4.49%)
F   20.24 (+1.30%)
DIS   137.34 (+0.61%)
AMC   17.47 (+9.05%)
PFE   53.20 (+1.26%)
ACB   4.25 (+0.95%)
BA   197.79 (-3.09%)
S&P 500   4,426.18 (+1.60%)
DOW   34,664.64 (+1.07%)
QQQ   352.88 (+2.25%)
AAPL   162.92 (+1.97%)
MSFT   301.66 (+4.57%)
FB   302.65 (+0.83%)
GOOGL   2,632.00 (+3.68%)
AMZN   2,836.55 (+1.32%)
TSLA   955.76 (+4.07%)
NVDA   233.39 (+4.55%)
BABA   116.19 (-2.48%)
NIO   23.72 (-0.29%)
AMD   113.86 (+2.46%)
CGC   7.61 (+3.40%)
MU   83.75 (+3.75%)
GE   90.71 (-0.44%)
T   25.29 (-4.49%)
F   20.24 (+1.30%)
DIS   137.34 (+0.61%)
AMC   17.47 (+9.05%)
PFE   53.20 (+1.26%)
ACB   4.25 (+0.95%)
BA   197.79 (-3.09%)
S&P 500   4,426.18 (+1.60%)
DOW   34,664.64 (+1.07%)
QQQ   352.88 (+2.25%)
AAPL   162.92 (+1.97%)
MSFT   301.66 (+4.57%)
FB   302.65 (+0.83%)
GOOGL   2,632.00 (+3.68%)
AMZN   2,836.55 (+1.32%)
TSLA   955.76 (+4.07%)
NVDA   233.39 (+4.55%)
BABA   116.19 (-2.48%)
NIO   23.72 (-0.29%)
AMD   113.86 (+2.46%)
CGC   7.61 (+3.40%)
MU   83.75 (+3.75%)
GE   90.71 (-0.44%)
T   25.29 (-4.49%)
F   20.24 (+1.30%)
DIS   137.34 (+0.61%)
AMC   17.47 (+9.05%)
PFE   53.20 (+1.26%)
ACB   4.25 (+0.95%)
BA   197.79 (-3.09%)
OTCMKTS:BIOAF

Bioasis Technologies Short Interest Ratio and Short Volume

$0.21
0.00 (0.00%)
(As of 01/25/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.20
$0.21
50-Day Range
$0.19
$0.25
52-Week Range
$0.18
$0.45
Volume
12,500 shs
Average Volume
24,900 shs
Market Capitalization
$15.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.05

Bioasis Technologies (OTCMKTS:BIOAF) Short Interest Data

Current Short Volume
1,500 shares
Previous Short Volume
32,500 shares
Change Vs. Previous Month
-95.38%
Dollar Volume Sold Short
$318.15
Short Interest Ratio / Days to Cover
0.1
Last Record Date
December, 31 2021
Outstanding Shares
72,144,000 shares
Percentage of Shares Shorted
0.00%
Today's Trading Volume
12,500 shares
Average Trading Volume
24,900 shares
Today's Volume Vs. Average
-49.80%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Bioasis Technologies ?

Sign up to receive the latest short interest report for Bioasis Technologies and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time


Bioasis Technologies (OTCMKTS:BIOAF) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/20211,500 shares $318.15 -95.4%N/A0.1 $0.21
12/15/202132,500 shares $6.56 thousand +733.3%N/A0.4 $0.20
11/30/20213,900 shares $873.60 +39.3%N/A0.1 $0.22
11/15/20212,800 shares $641.20 -95.0%N/A0 $0.23
10/29/202156,300 shares $12.94 thousand +12.2%N/A1.9 $0.23
10/15/202150,200 shares $11.94 thousand -19.6%N/A1.3 $0.24
9/30/202162,400 shares $15.06 thousand -1.6%N/A1.1 $0.24
9/15/202163,400 shares $13.05 thousand +93.9%N/A1.4 $0.21
8/31/202132,700 shares $6.46 thousand -36.6%N/A0.8 $0.20
8/13/202151,600 shares $10.84 thousand -21.3%N/A0.5 $0.21
7/30/202165,600 shares $15.81 thousand -22.6%N/A0.3 $0.24
7/15/202184,800 shares $26.19 thousand +21.0%N/A0.6 $0.31
6/30/202170,100 shares $19.49 thousand +47.3%N/A0.5 $0.28
6/15/202147,600 shares $14.28 thousand +13.3%N/A0.7 $0.30
5/28/202142,200 shares $9.50 thousand +29.9%N/A3 $0.23
5/14/202132,500 shares $6.49 thousand -42.3%N/A1.3 $0.20
4/30/202156,300 shares $12.89 thousand +136.6%N/A0.7 $0.23
4/15/202123,800 shares $7.33 thousand -48.2%N/A1.3 $0.31
3/31/202145,900 shares $14.69 thousand +95.3%N/A1.9 $0.32
3/15/202123,500 shares $7.74 thousand +319.6%N/A0.9 $0.33
2/26/20215,600 shares $2.13 thousand -76.7%N/A0 $0.38
2/12/202124,000 shares $10.14 thousand +4,700.0%N/A0.2 $0.42
1/29/2021500 shares $164.50 -98.3%N/A0 $0.33
1/15/202110,100 shares $3.62 thousand +573.3%N/A0.2 $0.36
12/31/202024,000 shares $6.33 thousand +137.6%N/A1.4 $0.26













Bioasis Technologies (OTCMKTS:BIOAF) Short Interest Frequently Asked Questions

What is Bioasis Technologies' current short interest?

Short interest is the volume of Bioasis Technologies shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 1,500 shares of BIOAF short. Learn More on Bioasis Technologies' current short interest.

Is Bioasis Technologies' short interest increasing or decreasing?

Bioasis Technologies saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 1,500 shares, a decline of 95.4% from the previous total of 32,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Bioasis Technologies' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Bioasis Technologies: Orgenesis Inc. (1.12%), Protara Therapeutics, Inc. (4.18%), Longboard Pharmaceuticals, Inc. (1.17%), Clever Leaves Holdings Inc. (0.00%), Chemomab Therapeutics Ltd. (0.30%), Oncotelic Therapeutics, Inc. (0.00%), Celyad Oncology SA (0.14%), Processa Pharmaceuticals, Inc. (2.38%), Biofrontera Inc. (63.34%), and Galecto, Inc. (1.41%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($9.39 billion), Advanced Micro Devices, Inc. ($9.08 billion), Charter Communications, Inc. ($7.16 billion), Palo Alto Networks, Inc. ($4.05 billion), Lucid Group Inc ($3.43 billion), Wayfair Inc. ($3.11 billion), Rivian ($3.05 billion), Datadog, Inc. ($2.76 billion), Zscaler, Inc. ($2.55 billion), and Etsy, Inc. ($1.99 billion). View all of the most shorted stocks.

What does it mean to sell short Bioasis Technologies stock?

Short selling BIOAF is an investing strategy that aims to generate trading profit from Bioasis Technologies as its price is falling. To short Bioasis Technologies stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Bioasis Technologies will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bioasis Technologies?

A short squeeze for Bioasis Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOAF, which in turn drives the price of the stock up even further.

How often is Bioasis Technologies' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOAF, twice per month. The most recent reporting period available is December, 31 2021.



This page was last updated on 1/26/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.